Survival following curative hepatic resection for hepatocellular carcinoma is limited by a high incidence of recurrence. Resection of extrahepatic recurrences has been shown to prolong survival in selected patients. We report two cases in whom repeated resections of extrahepatic metastases achieved good palliation and survival. The first patient had cerebral, pulmonary and splenic metastases that appeared more than four years following an extended left hepatectomy for a 4-cm hepatocellular carcinoma. Resection of the metastases in the three organs was performed in sequence, and the patient remained alive and asymptomatic 12 months after the metastatic recurrence. The second patient developed pulmonary metastases after an extended right hepa...
We report a case of advanced HCC with multiple intrahepatic metastases who obtained long-term surviv...
The recurrence rate after primary resection for hepatocellular carcinoma (HCC) has been reported to ...
Background: Hepatocellular carcinoma (HCC) is a common malignancy worldwide and treatment options ar...
A total of 277 patients with hepatocellular carcinoma (HCC) underwent hepatic resection over a 20-ye...
We identified 106 patients who had undergone complete resection of isolated colorectal hepatic metas...
BACKGROUND: Resection of hepatocellular carcinoma (HCC) is associated with a high incidence of recur...
BACKGROUND: A retrospective multiinstitutional study was performed to assess survival benefits of pa...
Background: Repeat liver resection because of recurrent colorectal liver metastases can provide surv...
Hepatocellular cancer (HCC) is increasing dramatically in incidence in Europe and the United States ...
OBJECTIVE: To evaluate the long-term results of aggressive treatment of HCC recurrence. METHODS: ...
Background: Resections are effective for some patients with both hepatic and pulmonary metastases of...
During a 4.5-year period, 5 patients underwent reresection of colorectal liver metastases. Two patie...
Although 5-year survival approaches 55% following resection of colorectal liver metastasis, most pat...
Background: The outcome after a repeat hepatectomy for recurrent colorectal liver metastases (CLM) ...
Hepatocellular carcinoma (HCC) is the third leading cause of death by cancer worldwide. The prognosi...
We report a case of advanced HCC with multiple intrahepatic metastases who obtained long-term surviv...
The recurrence rate after primary resection for hepatocellular carcinoma (HCC) has been reported to ...
Background: Hepatocellular carcinoma (HCC) is a common malignancy worldwide and treatment options ar...
A total of 277 patients with hepatocellular carcinoma (HCC) underwent hepatic resection over a 20-ye...
We identified 106 patients who had undergone complete resection of isolated colorectal hepatic metas...
BACKGROUND: Resection of hepatocellular carcinoma (HCC) is associated with a high incidence of recur...
BACKGROUND: A retrospective multiinstitutional study was performed to assess survival benefits of pa...
Background: Repeat liver resection because of recurrent colorectal liver metastases can provide surv...
Hepatocellular cancer (HCC) is increasing dramatically in incidence in Europe and the United States ...
OBJECTIVE: To evaluate the long-term results of aggressive treatment of HCC recurrence. METHODS: ...
Background: Resections are effective for some patients with both hepatic and pulmonary metastases of...
During a 4.5-year period, 5 patients underwent reresection of colorectal liver metastases. Two patie...
Although 5-year survival approaches 55% following resection of colorectal liver metastasis, most pat...
Background: The outcome after a repeat hepatectomy for recurrent colorectal liver metastases (CLM) ...
Hepatocellular carcinoma (HCC) is the third leading cause of death by cancer worldwide. The prognosi...
We report a case of advanced HCC with multiple intrahepatic metastases who obtained long-term surviv...
The recurrence rate after primary resection for hepatocellular carcinoma (HCC) has been reported to ...
Background: Hepatocellular carcinoma (HCC) is a common malignancy worldwide and treatment options ar...